Heal Squad' podcast host Maria Menounos, whose pancreatic cancer was discovered early enough to be treated, says, "If it ...
Labcorp plans to offer Roche’s recently FDA-cleared blood test to assess early signs of Alzheimer’s disease and other causes ...
Quest Diagnostics Incorporated shows post-pandemic growth with Q3 results, strategic expansion, and steady returns. Click for ...
Guardant Health received FDA approval for its Guardant360 CDx blood test as a companion diagnostic for Eli Lilly’s Inluriyo, targeting advanced breast cancer patients with ESR1 mutations. This ...
Strong growth, raised guidance, and new partnerships signal continued momentum amid regulatory and cost headwinds.
Laboratory operator Quest Diagnostics raised its full-year forecast for profit and revenue on Tuesday, banking on robust demand for its diagnostic tests, after posting strong results for the third ...
Quest Diagnostics Incorporated stock reached an all-time high of 191.87 USD, marking a significant milestone for the company. According to InvestingPro data, the company maintains a "GREAT" financial ...
A second blood test has been been approved by the US Food and Drug Administration to assist in diagnosing Alzheimer’s disease ...
Blood test to aid cancer treatment and recurrence monitoring now available from a German lab for potentially faster results ...
If you’re someone looking to be in the know about your health, the Watkins-Montour Rotary Club is offering a blood screening ...
The U.S. Food and Drug Administration has approved a second blood test to improve the detection of Alzheimer’s disease. The ...
Zacks Investment Research on MSN
Here's How Quest Diagnostics Is Placed Ahead of Q3 Earnings
Quest Diagnostics DGX is set to release its third-quarter 2025 results on Oct. 21, before the market opens. The renowned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback